SURGICEL BRAND ABSORBABLE HEMOSTAT
ETHICON, Inc. · Decision date Oct 14, 1960
What did the FDA approve?
FDA records N12159 as an original PMA application. The recorded decision is approval, dated Oct 14, 1960.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 14, 1960
Regulatory record facts
- Identifier
- N12159
- Regulatory pathway
- Premarket approval application
- Applicant
- ETHICON, Inc.
- Product code
- LMG
- Decision code
- APPR
- Decision date
- Oct 14, 1960
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, absorbable hemostatic, non-collagen based.
- Applicant
- ETHICON, Inc.
- Product code
- LMG
- FDA device class
- 3
FDA decision timeline
N12159 received
Application receipt date recorded by FDA.
N12159 · FDA decision
APPR
Related devices and submissions
Explore the linked device profile
Other records with product code LMG
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Baxter Healthcare Corporation | PMA supplement | Nov 7, 2026 | FDA | |
SURGICEL Absorbable HemostatsN12159/S132 | ETHICON, Inc. | PMA supplement | Nov 5, 2026 | FDA |
| Baxter Healthcare Corporation | PMA approval | May 19, 2023 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ETHICON, Inc.
- Headquarters
- Not reported
- Brand website
- ethicon.com
- FDA applicant address
- 1000 Rte. 202, Raritan, NJ, 08869
Sources and methodology
- Original FDA record: N12159
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records